Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Depletion of promotes neuroinflammatory attack against myelin in an experimental autoimmune encephalomyelitis mouse model.
TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis.
Comorbidity of uveitis and multiple sclerosis.
A pipeline to characterize spinal cord pathology in neurological disorders combining magnetic resonance microscopy and histopathology.
Peripheral Neuropathy Induced by a Short Course of Metronidazole: A Case Report of Diagnostic Challenge.
Microglial PD-1/PD-L1 axis in CNS demyelinating diseases: a dual immunoregulatory perspective.
Cerebellitis and cytotoxic lesions of the corpus callosum after COVID-19 infection.
Aloe-emodin promotes remyelination by driving microglial myelin debris clearance via the CD36-PPARγ axis.
Should autologous HSCT be a first-line option in highly active MS? Commentary.
Effect of the online Rethink My Drink alcohol intervention on alcohol use and cognition in older adults in Australia: a randomised controlled trial.
Natalizumab for pediatric multiple sclerosis: a systematic review and meta-analysis.
N-acetyl-L-leucine in Neurological Disorders: Mechanisms, Evidence, and Therapeutic Perspectives.
Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.
Should autologous HSCT be a first-line option in highly active MS: YES.
In vivo adenine base editing of mutant Galc gene ameliorates Krabbe disease progression.
Comment on "Spinal cord metabolism in multiple sclerosis: a decade of missed opportunities and future directions".
Pharmacological modulation of CXCL12/CXCR4/ACKR3 for brain disorders - an overview.
Charting the transition from in vitro gliogenesis to the in vivo maturation of human glial progenitor cells transplanted into the hypomyelinated mouse brain.
Human genetic and immunological determinants of Epstein-Barr virus-driven disease.
Associations of social isolation and loneliness with neurological disorders, psychiatric disorders, brain structures and behavioural phenotypes among UK Biobank participants.
Explainable Artificial Intelligence to Predict Neurocognitive Disorder Progression in Multiple Sclerosis Using MRI and Clinical Data.
Cholesterol in Myelin: Supply Routes, Pathological Consequences, Biophysical Governance, and Future Frontiers.
GABAB receptors in glial cells: from physiological regulation to pathological implications.
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.
Prodromal neurology: Is this the end of semiology?
Pages
« first
‹ previous
…
814
815
816
817
818
819
820
821
822
next ›
last »